MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer

European Journal of Cancer Prevention

Volumn 23, Issue 5, 2014, Pages 336-343

  Sipos, Ferenc ^a   Germann, Tiana M ^b   Wichmann, Barnabás ^a,c   Galamb, Orsolya ^a,c   Spisák, Sándor ^a,c   Krenács, Tibor ^a   Tulassay, Zsolt ^a,c   Molnár, Béla ^a,c   Muzes, Györgyi ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

colorectal cancer; CXCL1; dysplasia carcinoma transition; MMP3; sessile adenoma; tissue microarrays

Indexed keywords

CXCL1 CHEMOKINE; STROMELYSIN; TUMOR MARKER; CXCL1 PROTEIN, HUMAN; MESSENGER RNA; MMP3 PROTEIN, HUMAN;

ARTICLE; AUTOMATION; CANCER GRADING; CANCER STAGING; COLON BIOPSY; COLORECTAL CANCER; COLORECTAL DYSPLASIA CARCINOMA TRANSITION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; ADENOMA; ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; COLON; COLORECTAL NEOPLASMS; ENZYME IMMUNOASSAY; FOLLOW UP; GENE EXPRESSION PROFILING; GENETICS; HYPERPLASIA; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; VERY ELDERLY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CHEMOKINE CXCL1; COLON; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84906101392     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000058     Document Type: Article

References (25)

1. Baier PK, Eggstein S, Wolff-Vorbeck G, Baumgartner U, Hopt UT (2005). Chemokines in human colorectal carcinoma. Anticancer Res 25:3581-3584.
2. Bechara C, Chai H, Lin PH, Yao Q, Chen C (2007). Growth related oncogenealpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med Sci Monit 13:RA87-RA90.
3. Bousserouel S, Gosse F, Bouhadjar M, Soler L, Marescaux J, Raul F (2010). Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis. Oncol Rep 23:511-517.
4. Deryugina EI, Quigley JP (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9-34.
5. Galamb O, Sipos F, Solymosi N, Spisák S, Krenács T, Tóth K, et al. (2008). Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimens and their correlation with peripheral blood results. Cancer Epidemiol Biomarkers Prev 17:2835-2845.
6. Galamb O, Sipos F, Spisák S, Galamb B, Krenács T, Valcz G, et al. (2009). Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes. Cell Oncol 31:19-29.
7. Galamb O, Wichmann B, Sipos F, Spisák S, Krenács T, Tóth K, et al. (2012). Dysplasia-carcinoma transition specific transcripts in colonic biopsy samples. PLoS One 7:e48547.
8. Jeffery N, McLean MH, El-Omar EM, Murray GI (2009). The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Histopathology 54:820-828.
9. Jodele S, Blavier L, Yoon JM, DeClerck YA (2006). Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25:35-43.
10. Krecsák L, Micsik T, Kiszler G, Krenács T, Szabó D, Jónás V, et al. (2011). Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer. Diagn Pathol 6:6.
11. Krenacs T, Zsakovics I, Diczhazi C, Ficsor L, Varga VS, Molnar B (2009). The potential of digital microscopy in breast pathology. Pathol Oncol Res 15:55-58.
12. Li CK, Pender SL, Pickard KM, Chance V, Holloway JA, Huett A, et al. (2004). Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice. J Immunol 173:5171-5179.
13. Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y (2012). Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS One 7:e31251.
14. Michielsen AJ, Hogan AE, Marry J, Tosetto M, Cox F, Hyland JM, et al. (2011). Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer. PLoS One 6:e27944.
15. Mott JD, Werb Z (2004). Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16:558-564.
16. Nastase A, Pâslaru L, Niculescu AM, Ionescu M, Dumitraşcu T, Herlea V, et al. (2011). Prognostic and predictive potential molecular biomarkers in colon cancer. Chirurgia (Bucur) 106:177-185.
17. Overall CM, Kleifeld O (2006). Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and antitargets for cancer therapy. Nat Rev Cancer 6:227-239.
18. Piperi C, Papavassiliou AG (2012). Molecular mechanisms regulating matrix metalloproteinases. Curr Top Med Chem 12:1095-1112.
19. Spisák S, Galamb B, Sipos F, Galamb O, Wichmann B, Solymosi N, et al. (2010). Applicability of antibody and mRNA expression microarrays for identifying diagnostic and progression markers of early and late stage colorectal cancer. Dis Markers 28:1-14.
20. Stamenkovic I (2003). Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448-464.
21. Strieter RM, Belperio JA, Phillips RJ, Keane MP (2004). CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 14:195-200.
22. Varga VS, Molnár B, Virág T (2012). Automated high throughput whole slide imaging using area sensors, flash light illumination and solid state light engine. Stud Health Technol Inform 179:187-202.
23. Wu ML, Varga VS, Kamaras V, Ficsor L, Tagscherer A, Tulassay Z, Molnar B (2005). Three-dimensional virtual microscopy of colorectal biopsies. Arch Pathol Lab Med 129:507-510.
24. Yoo J, Rodriguez Perez CE, Nie W, Sinnett-Smith J, Rozengurt E (2011). Protein kinase D1 mediates synergistic MMP-3 expression induced by TNF- α and bradykinin in human colonic myofibroblasts. Biochem Biophys Res Commun 413:30-35.
25. Zisman TL, Rubin DT (2008). Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol 14:2662-2669.